TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy

Dr Kaklamani talks to ecancertv at SABCS 2015 about results from the ongoing, prospective Trial Assigning Individualized Options for Treatment (TAILORx) involving more than 10,000 women with estrogen receptor (ER)-positive, HER2-negative, axillary…

from #ORL-AlexandrosSfakianakis via simeraentaxei on Inoreader http://ift.tt/1ZqIORV
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1RIqpPp
via IFTTT